Who owns Rigel Pharmaceuticals?

Key details on Rigel Pharmaceuticals (Ticker: RIGL)

Who owns Rigel Pharmaceuticals?

Is RIGL a good stock to own? Find out who bought Rigel Pharmaceuticals, who sold Rigel Pharmaceuticals (RIGL) stock, and who holds a large position in Rigel Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 13.22M $42.44M June 30, 2015
Broadfin Capital 8.50M $19.30M Dec. 31, 2014
Palo Alto Investors 5.18M $16.62M June 30, 2015
OppenheimerFunds 5.00M $16.05M June 30, 2015
Wellington Management Company 5.00M $16.04M June 30, 2015
T. Rowe Price Associates 4.61M $16.51M Sept. 30, 2013
STATE STREET CORPORATION 3.90M $13.03M June 30, 2013
BlackRock Institutional Trust Company, N.A. 3.42M $10.99M June 30, 2015
NEA Management Company 3.24M $10.41M June 30, 2015
Vanguard 3.17M $10.17M June 30, 2015
Millennium Management 3.06M $5.93M Sept. 30, 2014
BVF 2.58M $10.00M March 31, 2014
Deerfield Management Company 2.40M $8.56M March 31, 2015
BlackRock Fund Advisors 2.30M $7.39M June 30, 2015